If you are experiencing excessive daytime sleepiness due to narcolepsy, consider the Vibrance Studies.
The Vibrance Studies are currently enrolling adults 18–70 years of age with narcolepsy type 1 (NT1) or narcolepsy type 2 (NT2) to research an investigational study drug taken orally once daily. If you are interested in taking part, please complete the questionnaire below to assess your eligibility.
Individuals with NT1 may be eligible for the Vibrance-1 Study, and individuals with NT2 may be eligible for the Vibrance-2 Study.
Learn more about the Vibrance Studies
*Indicates required field.
If you are interested in taking part in one of the Vibrance Studies, please continue below and complete the questionnaire to see if you may be eligible.
Step 1 of 3
By answering the following questions, you are not obligated to participate in this clinical research study. At the end of the questionnaire, you will have the opportunity to decide whether or not your answers are saved or submitted to a local research site to discuss the study further.
e.g., 12345
MM/DD/YYYY
This website uses Secure Socket Layer technology and encryption methods to protect personal health information. If you’d like to know more about this, read the privacy policy.
Step 2 of 3
By clicking the “Continue” button and completing this questionnaire, you are agreeing to have your information retained for the duration of the study, as well as to having a research site contact you.